Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
In: Microorganisms, Jg. 9 (2021-08-04), Heft 1666, p 1666, S. 1666-1666
Online
unknown
Zugriff:
The treatment options for cytomegalovirus (CMV) infections in immunosuppressed patients are limited, mainly consisting of (val-)ganciclovir (VGC/GCV) as the first-line treatment. We report on three transplant recipients, one stem cell transplant (allo-HSCT) patient and two kidney transplant (KTx) recipients, with prolonged CMV viremia treated with a combined therapy based on letermovir (LMV), CMV-specific intravenous immunoglobulins (IVIg), and VGC/GCV, which led to the sustained control of CMV viremia in all patients.
Titel: |
Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
|
---|---|
Autor/in / Beteiligte Person: | Affeldt, Patrick ; Stippel, Dirk L. ; Müller, Roman-Ulrich ; Holtick, Udo ; Kurschat, Christine ; Scheid, Christoph ; Kann, Martin ; Kaiser, Rolf ; Knops, Elena ; Wirtz, Maike ; Grundmann, Franziska ; Trappe, Moritz ; Heger, Eva ; Veronica Di Cristanziano |
Link: | |
Zeitschrift: | Microorganisms, Jg. 9 (2021-08-04), Heft 1666, p 1666, S. 1666-1666 |
Veröffentlichung: | MDPI AG, 2021 |
Medientyp: | unknown |
ISSN: | 2076-2607 (print) |
DOI: | 10.3390/microorganisms9081666 |
Schlagwort: |
|
Sonstiges: |
|